Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
2ND FY22 Delivery Order - Cost Per Test Reagents at Tripler Army Medical Center, Hi is a federal award for W40m Mrco Pacific held by Roche Diagnostics Corp. Estimated value $177K ($177K obligated). Current period of performance ends Sep 30, 2022. Place of performance: INDIANAPOLIS IN. Related solicitation W81K0221Q0147.
2nd fy22 delivery order - cost per test reagents at tripler army medical center, hi
Recompete timing
PublicCurrent PoP ended Sep 30, 2022 (1482 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on W81K0222F0063? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0222F0063?
W81K0222F0063 (2nd fy22 delivery order - cost) is a W40m Mrco Pacific award with a potential value of $177K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W81K02-22-F-0063?
W81K02-22-F-0063 is the dashed form of PIID W81K0222F0063 (2nd fy22 delivery order - cost), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W81K0222F0063?
W40m Mrco Pacific awarded W81K0222F0063 to Roche Diagnostics Corp (potential $177K).
Who is the incumbent on W81K0222F0063?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2022.
When does Roche Diagnostics Corp’s W81K0222F0063 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on W81K0222F0063? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.